Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults
Status:
Completed
Trial end date:
2019-05-27
Target enrollment:
Participant gender:
Summary
Phase I/II, open, prospective clinical trial, historically controlled. The objective is to
evaluate the safety and, as a secondary measure, the efficacy of an experimental treatment
based on a cellular therapy (vaccination with autologous dendritic cells pulsed with tumor
lysate) in patients affected of metastatic or relapsed sarcomas or (Central Nervous System)
CNS tumors.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Clinica Universidad de Navarra, Universidad de Navarra